drugset / Trial / NCT02541669
A Single- and Multiple-Dose Study of the Pharmacokinetics of TAK-491 in Healthy Chinese Participants
RandomizedParallel-groupQuadruple-blindOther
Summary
The purpose of this study is to assess the pharmacokinetics and safety of single- and multiple-dose of TAK-491 in healthy Chinese participants.
Timeline
- Start
- 2015-11-20
- Primary completion
- 2017-03-17
- Completion
- 2017-03-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azilsartan medoxomil | Other / unclassified | 40 mg | — |
| Subject | Azilsartan medoxomil | Other / unclassified | 80 mg | — |
Indications
No indication recorded.